Evidence map›Paper›PMID 9326318›Full record

ArticleAmerican journal of human genetics1997

Transglutaminase 1 mutations in autosomal recessive congenital ichthyosis: private and recurrent mutations in an isolated population.

E Laiho, J Ignatius, H Mikkola, V C Yee, D C Teller, K M Niemi, U Saarialho-Kere, J Kere, A Palotie

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Compound Heterozygous Mutations inPharmacogenomics and personalized medicine · 2022
    Article
  5. Article
  6. Review
  7. Characterization of Epidermal Lipoxygenase Expression in Normal Human Skin and Tissue-Engineered Skin Substitutes.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2018
    Article
  8. Article
  9. Article
  10. Epidermal barriers.Cold Spring Harbor perspectives in medicine · 2014
    Review
  11. Article
  12. Transglutaminase-1 mutations in Omani families with lamellar ichthyosis.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2013
    Article
  13. Article
  14. Updated molecular genetics and pathogenesis of ichthiyoses.Nagoya journal of medical science · 2011
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. End-stage renal failure in a child with X-linked ichthyosis.Pediatric nephrology (Berlin, Germany) · 2003
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

E LaihoDepartment of Clinical Chemistry, University of Helsinki, Finland.
J Ignatius
H Mikkola
V C Yee
D C Teller
K M Niemi
U Saarialho-Kere
J Kere
A Palotie
Helsinki University Hospital · FIUniversity of Washington · USInstitute of Genetics · HUUniversity of Helsinki · FIVäestöliitto · FI

Funding

STRUCTURE AND MECHANISM OF FACTOR XIIIR01HL050355 · NHLBI · UNIVERSITY OF WASHINGTON · PI STENKAMP, RONALD E · 1994 to 1999
–
NHLBI NIH HHS HL-50355
6 · The paper itself

Abstract

Autosomal recessive congenital ichthyosis (ARCI) is a rare, heterogenous keratinization disorder of the skin, classically divided into two clinical subtypes, lamellar ichthyosis (LI) and nonbullous congenital ichthyosiformis erythroderma (CIE). Recently, strong evidence for the involvement of the transglutaminase 1 gene (TGM1) in LI has evolved. We have studied ARCI in the isolated Finnish population, in which recessive disorders are often caused by single mutations enriched by a founder effect. Surprisingly, five different mutations of TGM1 (Arg141His, Arg142Cys, Gly217Ser, Val378Leu, and Arg395Leu) were found in Finnish ARCI patients. In addition to affected LI patients, we also identified TGM1 mutations in CIE patients. Moreover, haplotype analysis of the chromosomes carrying the most common mutation, a C-->T transition changing Arg142 to Cys, revealed that the same mutation has been introduced twice in the Finnish population. In addition to this Arg142Cys mutation, three other mutations, in Arg141 and Arg142, have been described elsewhere, in other populations. These findings suggest that this region of TGM1 is more susceptible to mutation. The corresponding amino acid sequence is conserved in other transglutaminases, but, for example, coagulation factor XIII (FXIII) mutations do not cluster in this region. Protein modeling of the Arg142Cys mutation suggested disruption or destabilization of the protein. In transfection studies, the closely related transglutaminase FXIII protein with the corresponding mutation was shown to be susceptible to degradation in COS cells, further supporting evidence of the destabilizing effect of the Arg142Cys mutation in TGM1.

Indexed as

AdolescentAdultAnimalsChildCOS CellsDNA Mutational AnalysisFemaleFinlandHaplotypesHumansIchthyosis, LamellarInfantMaleMiddle AgedPedigreePoint MutationRNA, Messengertransglutaminase 1Transglutaminases

Identifiers

PMID9326318
PMCPMC1715945
OpenAlexW2005245057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.